Three Covid-19 treatments including Merck’s antiviral pill approved

Published: Apr 8, 2022 2:36 AM | Updated: Apr 8, 2022 1:06 PM

The Drug Control Authority (DCA) has approved Merck’s molnupiravir for Covid-19 treatment yesterday, making it the second antiviral pill to be approved in Malaysia for treating the disease.

The DCA previously granted provisional approval for Pfizer’s Paxlovid (a pill consisting of nirmatrelvir and ritonavir) in March.

Both drugs are meant to be administered during the early phases of a Covid-19 infection to reduce...

Covid-19 (April 7): 11,994 new cases, 36 deaths

DCA approves Sinovac vaccine for children, Pfizer's Covid pill

WHO recommends Merck Covid pill for high-risk patients

Pfizer urged to sell more Covid pills to developing countries

Cheap version of Merck Covid pill to be made for poorer nations

Indonesia to begin local production of Covid-19 antiviral pills soon

Comments0

By posting a comment, you agree to our Commenting Terms and Conditions as stipulated in full here.

Do's and don'ts when posting comments in Malaysiakini

TERMS & CONDITIONS

Foul language, profanity, vulgarity, slanderous, personal attack, threatening, sexually-orientated comments or the use of any method of communication that may violate any law or create needless unpleasantness will not be tolerated. Antisocial behaviour such as "spamming" and "trolling" will be suspended. Violators run the risk of also being blocked permanently.

REPORT VIOLATORS

Please use the report feature that is available below each comment to flag offending comments for our moderators to take action. Do not take matters in your own hands to avoid unpleasant and unnecessary exchanges that may result in your own suspension or ban.

NOTICE

Our commenting system is still under development. We have taken note of feedback provided.

Subscriber-only space: